These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 1708400)

  • 1. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the dipyridodiazepinone BI-RG-587.
    Koup RA; Merluzzi VJ; Hargrave KD; Adams J; Grozinger K; Eckner RJ; Sullivan JL
    J Infect Dis; 1991 May; 163(5):966-70. PubMed ID: 1708400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor.
    Merluzzi VJ; Hargrave KD; Labadia M; Grozinger K; Skoog M; Wu JC; Shih CK; Eckner K; Hattox S; Adams J
    Science; 1990 Dec; 250(4986):1411-3. PubMed ID: 1701568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 reverse transcriptase inhibition by a dipyridodiazepinone derivative: BI-RG-587.
    Tramontano E; Cheng YC
    Biochem Pharmacol; 1992 Mar; 43(6):1371-6. PubMed ID: 1373283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine.
    Richman D; Rosenthal AS; Skoog M; Eckner RJ; Chou TC; Sabo JP; Merluzzi VJ
    Antimicrob Agents Chemother; 1991 Feb; 35(2):305-8. PubMed ID: 1708976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of HIV-1 reverse transcriptase and virus replication by a non-nucleoside dipyridodiazepinone BI-RG-587 (Nevirapine).
    Skoog MT; Hargrave KD; Miglietta JJ; Kopp EB; Merluzzi VJ
    Med Res Rev; 1992 Jan; 12(1):27-40. PubMed ID: 1371177
    [No Abstract]   [Full Text] [Related]  

  • 6. Nevirapine synergistically inhibits HIV-1 replication in combination with zidovudine, interferon or CD4 immunoadhesin.
    Koup RA; Brewster F; Grob P; Sullivan JL
    AIDS; 1993 Sep; 7(9):1181-4. PubMed ID: 7692883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steady state kinetics and inhibition of HIV-1 reverse transcriptase by a non-nucleoside dipyridodiazepinone, BI-RG-587, using a heteropolymeric template.
    Kopp EB; Miglietta JJ; Shrutkowski AG; Shih CK; Grob PM; Skoog MT
    Nucleic Acids Res; 1991 Jun; 19(11):3035-9. PubMed ID: 1711678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
    Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R
    Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral properties of palinavir, a potent inhibitor of the human immunodeficiency virus type 1 protease.
    Lamarre D; Croteau G; Wardrop E; Bourgon L; Thibeault D; Clouette C; Vaillancourt M; Cohen E; Pargellis C; Yoakim C; Anderson PC
    Antimicrob Agents Chemother; 1997 May; 41(5):965-71. PubMed ID: 9145853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity.
    Goldman ME; Nunberg JH; O'Brien JA; Quintero JC; Schleif WA; Freund KF; Gaul SL; Saari WS; Wai JS; Hoffman JM
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6863-7. PubMed ID: 1713693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective and synergistic inhibition of human immunodeficiency virus type 1 reverse transcriptase by a non-nucleoside inhibitor, MKC-442.
    Yuasa S; Sadakata Y; Takashima H; Sekiya K; Inouye N; Ubasawa M; Baba M
    Mol Pharmacol; 1993 Oct; 44(4):895-900. PubMed ID: 7694070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site.
    Wu JC; Warren TC; Adams J; Proudfoot J; Skiles J; Raghavan P; Perry C; Potocki I; Farina PR; Grob PM
    Biochemistry; 1991 Feb; 30(8):2022-6. PubMed ID: 1705436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro selection and molecular characterization of human immunodeficiency virus-1 resistant to non-nucleoside inhibitors of reverse transcriptase.
    Mellors JW; Dutschman GE; Im GJ; Tramontano E; Winkler SR; Cheng YC
    Mol Pharmacol; 1992 Mar; 41(3):446-51. PubMed ID: 1372083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human immunodeficiency virus type 1 replication by combination of transcription inhibitor K-12 and other antiretroviral agents in acutely and chronically infected cells.
    Okamoto M; Okamoto T; Baba M
    Antimicrob Agents Chemother; 1999 Mar; 43(3):492-7. PubMed ID: 10049256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture.
    Richman D; Shih CK; Lowy I; Rose J; Prodanovich P; Goff S; Griffin J
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11241-5. PubMed ID: 1722324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mode of action of 5'-linked cholesteryl phosphorothioate oligodeoxynucleotides in inhibiting syncytia formation and infection by HIV-1 and HIV-2 in vitro.
    Stein CA; Pal R; DeVico AL; Hoke G; Mumbauer S; Kinstler O; Sarngadharan MG; Letsinger RL
    Biochemistry; 1991 Mar; 30(9):2439-44. PubMed ID: 1705817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro comparison of selected triple-drug combinations for suppression of HIV-1 replication: the Inter-Company Collaboration Protocol.
    St Clair MH; Pennington KN; Rooney J; Barry DW
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 2():S83-91. PubMed ID: 7552518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus 1 (HIV-1)-specific reverse transcriptase (RT) inhibitors may suppress the replication of specific drug-resistant (E138K)RT HIV-1 mutants or select for highly resistant (Y181C-->C181I)RT HIV-1 mutants.
    Balzarini J; Karlsson A; Sardana VV; Emini EA; Camarasa MJ; De Clercq E
    Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6599-603. PubMed ID: 7517553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human immunodeficiency virus type 1 replication by phosphonoformate esters of 3'-azido-3'-deoxythymidine.
    Rosowsky A; Saha J; Fazely F; Koch J; Ruprecht RM
    Biochem Biophys Res Commun; 1990 Oct; 172(1):288-94. PubMed ID: 2222476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrido [1,2a] indole derivatives identified as novel non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1.
    Taylor DL; Ahmed PS; Chambers P; Tyms AS; Bedard J; Duchaine J; Falardeau G; Lavallée JF; Brown W; Rando RF; Bowlin T
    Antivir Chem Chemother; 1999 Mar; 10(2):79-86. PubMed ID: 10335402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.